 A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER, ACTIVE DRUG CONTROLLED, PHASE III CLINICAL TRIAL TO COMPARE THE SAFETY AND EFFICACY OF DWP450 VERSUS BOTOX IN TREATMENT OF POST STROKE UPPER LIMB SPASTICITY: 